|
|
Original Articles |
| Neuropathology in multiple sclerosis: new concepts |
93 |
| Hans Lassmann
|
|
Abstract
Full Article (PDF)
|
|
| Cerebrospinal fluid - physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases |
99 |
| Hansotto Reiber
|
|
Abstract
Full Article (PDF)
|
|
| Composite cerebrospinal fluid score in relapsing-remitting and secondary progressive multiple sclerosis |
108 |
| PJH Jongen,
S Floris,
WH Doesburg,
WAJG Lemmens,
OR Hommes & KJB Lamers
|
|
Abstract
Full Article (PDF)
|
|
| The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis |
111 |
| H Reiber,
S Ungefehr & Chr Jacobi
|
|
Abstract
Full Article (PDF)
|
|
| CSF-enriched antibodies do not share specificities among MS patients |
118 |
| I Cortese,
S Capone,
S Luchetti,
LME Grimaldi,
A Nicosia & R Cortese
|
|
Abstract
Full Article (PDF)
|
|
| Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis |
124 |
| KJB Lamers,
HPM de Reus & PJH Jongen
|
|
Abstract
Full Article (PDF)
|
|
| MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis |
127 |
| Finn Sellebjerg,
Michael Christiansen & Peter Garred
|
|
Abstract
Full Article (PDF)
|
|
| Can CSF predict the course of optic neuritis? |
132 |
| JL Frederiksen
|
|
Abstract
Full Article (PDF)
|
|
| Immune pathogenesis of multiple sclerosis. Brain autoimmune reactivity and its control by neuronal function |
136 |
| Hartmut Wekerle
|
|
Abstract
Full Article (PDF)
|
|
| Are there any body fluid markers of brain atrophy in multiple sclerosis? |
138 |
| G Giovannoni,
AJE Green & EJ Thompson
|
|
Abstract
Full Article (PDF)
|
|
| Data on cytokine mRNA expression in CSF and peripheral blood mononuclear cells from MS patients as detected by PCR |
143 |
| Philippe Monteyne & Christian JM Sindic
|
|
Abstract
Full Article (PDF)
|
|
| Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide |
147 |
| JD Laman,
CBM Maassen,
MM Schellekens,
L Visser,
M Kap,
E de Jong,
M van Puijenbroek,
MJB van Stipdonk,
M van Meurs,
C Schwärzler & U Günthert
|
|
Abstract
Full Article (PDF)
|
|
T cell receptor V 5 and V17 clonal diversity in cerebrospinal fluid and peripheral blood lymphocytes of multiple sclerosis patients |
154 |
| P Lozeron,
D Chabas,
B Duprey,
O Lyon-Caen & R Liblau
|
|
Abstract
Full Article (PDF)
|
|
| Monocyte activation in multiple sclerosis |
162 |
Anthony T Reder,
Kur ad Genç,
Paul V Byskosh & Anna Maria Porrini
|
|
Abstract
Full Article (PDF)
|
|
| Cytokines in multiple sclerosis: pro-inflammation or pro-remyelination? |
169 |
| MK Sharief
|
|
Abstract
Full Article (PDF)
|
|
| Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon- 1b-treated multiple sclerosis patients |
174 |
| AM Ferrarini,
S Sivieri,
M Buttarello,
A Facchinetti,
P Perini & P Gallo
|
|
Abstract
Full Article (PDF)
|
|
| Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis |
178 |
| Peter Rieckmann,
Bernd Altenhofen,
Antje Riegel,
Boris Kallmann & K Felgenhauer
|
|
Abstract
Full Article (PDF)
|
|
| Serum soluble intercellular adhesion molecule-1 in MS: relation to clinical and Gd-MRI activity and to rIFN-1b treatment |
183 |
| M Trojano,
C Avolio,
M Ruggieri,
G Defazio,
F Giuliani,
D Paolicelli & P Livrea
|
|
Abstract
Full Article (PDF)
|
|
| Monitoring Multiple Sclerosis course and activity with TNF-alpha |
188 |
| Michel Chofflon & Benoît Fellay
|
|
Abstract
Full Article (PDF)
|
|
| Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations? |
193 |
| Jan Debruyne,
Jan Philippé,
Jacques Dereuck,
Annick Willems & Geert Leroux-Roels
|
|
Abstract
Full Article (PDF)
|
|
| In vitro cytokine profiles as indicators of relapse activity and clinical course in multiple sclerosis |
198 |
| Myriam Schluep,
Guy van Melle,
Hugues Henry,
Claudio Städler,
Béatrice Roth-Wicky & Pierre J Magistretti
|
|
Abstract
Full Article (PDF)
|
|
| Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis |
203 |
| Piet Stinissen,
Robert Medaer & Jef Raus
|
|
Abstract
Full Article (PDF)
|
|
| The potential role of nitric oxide in multiple sclerosis |
212 |
| G Giovannoni,
SJR Heales,
JM Land & EJ Thompson
|
|
Abstract
Full Article (PDF)
|
|
| A unique population of circulating autoantibodies promotes central nervous system remyelination |
217 |
| K Asakura & M Rodriguez
|
|
Abstract
Full Article (PDF)
|
|
| A gene therapy approach to treat demyelinating diseases using non-replicative herpetic vectors engineered to produce cytokines |
222 |
| G Martino,
R Furlan,
F Galbiati,
PL Poliani,
A Bergami,
LME Grimaldi,
L Adorini & G Comi
|
|
Abstract
Full Article (PDF)
|
|
| Are there indicators of remyelination in blood or CSF of multiple sclerosis patients? |
228 |
| AR Massaro
|
|
Abstract
Full Article (PDF)
|
|
| Disease activity and the immune set in multiple sclerosis: blood markers for immunotherapy |
232 |
| AJ Coles,
MG Wing & DAS Compston
|
|
Abstract
Full Article (PDF)
|
|
| The expression of integrins on activated T-cells in multiple sclerosis. Effect of intravenous methylprednisolone treatment |
239 |
| S Luján,
J Masjuan,
E Roldán,
LM Villar,
P González-Porqué & JC Álvarez-Cermeño
|
|
Abstract
Full Article (PDF)
|
|
| Myelin basic protein-like material in the urine of multiple sclerosis patients: relationships to clinical and neuroimaging changes |
243 |
| John N Whitaker
|
|
Abstract
Full Article (PDF)
|
|
| Urinary markers of disease activity in multiple sclerosis |
247 |
| G Giovannoni & EJ Thompson
|
|
Abstract
Full Article (PDF)
|
|
| Free light chains in multiple sclerosis urine |
254 |
| PD Mehta,
SD Cook,
PK Coyle,
RA Troiano,
CS Constantinescu & AM Rostami
|
|
Abstract
Full Article (PDF)
|
|
| Identification of brain atrophy with MRI in MS |
257 |
| Alan J Thompson
|
|
Abstract
Full Article (PDF)
|
|
| Neurophysiological and cognitive markers of disease evolution in multiple sclerosis |
260 |
| G Comi,
V Martinelli,
T Locatelli,
L Leocani & S Medaglini
|
|
Abstract
Full Article (PDF)
|
|
| Body fluid markers to monitor multiple sclerosis: the assays and the challenges |
266 |
| JD Laman,
EJ Thompson & L Kappos
|
|
Abstract
Full Article (PDF)
|
|